Last reviewed · How we verify

NCT04045444: OXYSENIOR

Cerebral Oxygenation During Gait in Elderly

Completed NA Last updated 1 September 2021
What this trial tests

NA trial testing walking in Cerebral Oxygenation in 117 participants. Completed in 20 April 2021.

Timeline
25 February 2019
Primary endpoint
20 April 2021
20 April 2021

Quick facts

Lead sponsorCentre Hospitalier Régional d'Orléans
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment117
Start date25 February 2019
Primary completion20 April 2021
Estimated completion20 April 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Régional d'Orléans

Who can join

Adults 18 to 30, any sex, with Cerebral Oxygenation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ageing is accompanied by a cognitive decline altering gait and increasing the risk of falling. Physical activity could reduce this cognitive decline by an improvement in the oxygen supply to the brain. At the moment, the effect of physical activity on brain oxygenation during walking in elderly has never been described. Moreover, the increase in cognitive request during a dual task could lead to an increase in the risk of falling. In this context, the investigators of Orleans's hospital want to examine the effect of the physical activity level of elderly on their brain oxygenation during walking and during a dual task. Moreover, Parkinson' patients could display an impairment of gait and cognitive function. Attentional task and dual task situation are particularly impaired in this pathology. This is why the investigators of Orleans's hospital want to also examine cerebral activation of these patients during walking and during a dual task. The hemodynamic cerebral activation will be studied using the near infrared spectroscopy at the level of the prefrontal cortex. This non-invasive technic allows the evaluation of the regional oxyhemoglobin and deoxyhemoglobin variations induced by cerebral activation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of walking

Trials testing the same drug.

Other recruiting trials for Cerebral Oxygenation

Currently open trials in the same condition.

Other Centre Hospitalier Régional d'Orléans trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04045444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing